Leerink Swann restated their buy rating on shares of Team Health Holdings Inc. (NYSE:TMH) in a report published on Wednesday morning.

Several other equities research analysts also recently issued reports on TMH. Bank of America Corp. restated a buy rating and issued a $52.00 price objective on shares of Team Health Holdings in a research note on Tuesday, June 21st. Barclays PLC restated a buy rating on shares of Team Health Holdings in a research note on Sunday, July 10th. Zacks Investment Research downgraded shares of Team Health Holdings from a hold rating to a sell rating in a research note on Tuesday, July 19th. SunTrust Banks Inc. lowered their price objective on shares of Team Health Holdings from $54.00 to $50.00 and set a buy rating on the stock in a research note on Thursday, August 4th. Finally, Mizuho lowered their price objective on shares of Team Health Holdings from $47.00 to $38.00 and set a neutral rating on the stock in a research note on Friday, August 5th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and eleven have assigned a buy rating to the stock. Team Health Holdings has a consensus rating of Buy and an average price target of $47.27.

Team Health Holdings (NYSE:TMH) traded down 1.00% during trading on Wednesday, hitting $39.50. 1,180,836 shares of the stock traded hands. Team Health Holdings has a one year low of $30.83 and a one year high of $63.56. The company has a 50-day moving average price of $33.70 and a 200 day moving average price of $40.27. The stock has a market cap of $2.93 billion, a PE ratio of 65.40 and a beta of 1.18.

Team Health Holdings (NYSE:TMH) last announced its quarterly earnings data on Tuesday, August 2nd. The company reported $0.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.65 by $0.01. The business had revenue of $1.12 billion for the quarter, compared to the consensus estimate of $1.17 billion. Team Health Holdings had a net margin of 0.74% and a return on equity of 29.71%. Team Health Holdings’s quarterly revenue was up 27.9% on a year-over-year basis. During the same quarter last year, the company posted $0.70 earnings per share. Analysts expect that Team Health Holdings will post $2.68 earnings per share for the current year.

Hedge funds have recently made changes to their positions in the stock. Jana Partners LLC acquired a new stake in shares of Team Health Holdings during the first quarter worth $246,276,000. Sachem Head Capital Management LP acquired a new stake in shares of Team Health Holdings during the first quarter worth $133,792,000. Norges Bank acquired a new stake in shares of Team Health Holdings during the fourth quarter worth $38,408,000. Wellington Management Group LLP raised its stake in shares of Team Health Holdings by 11.8% in the first quarter. Wellington Management Group LLP now owns 7,157,446 shares of the company’s stock worth $299,253,000 after buying an additional 755,537 shares during the period. Finally, FMR LLC raised its stake in shares of Team Health Holdings by 5.3% in the second quarter. FMR LLC now owns 9,360,287 shares of the company’s stock worth $380,682,000 after buying an additional 470,691 shares during the period.

About Team Health Holdings

Team Health Holdings, Inc (TeamHealth) is a provider of outsourced healthcare professional staffing and administrative services to hospitals and other healthcare providers. The Company operates through four segments: Hospital Based Services, IPC Healthcare, Specialty Services and Other Services. The Hospital Based Services segment provides healthcare service programs to users of healthcare services on a fee for service, as well as a cost plus or contract basis.

5 Day Chart for NYSE:TMH

Receive News & Stock Ratings for Team Health Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Team Health Holdings Inc. and related stocks with our FREE daily email newsletter.